CBT

Cabot Corporation (CBT) - Q1 Fiscal 2026 10-Q Summary

Business Context and Reporting Period

This filing covers the quarterly period ended December 31, 2025 (First Quarter of Fiscal 2026). Cabot Corporation operates two reportable segments: Reinforcement Materials (carbon black) and Performance Chemicals (specialty carbons, fumed metal oxides, battery materials, etc.). The company is a large accelerated filer incorporated in Delaware.

Key Financial Metrics

Note: Total Debt calculated as Short-term borrowings ($12M) + Current portion of long-term debt ($260M) + Long-term debt ($854M).

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased by $106 million (11.1%) year-over-year. This was driven by less favorable pricing and product mix ($61M) and lower volumes ($56M), partially offset by favorable foreign currency translation ($15M).
• Segment Performance:
  • Reinforcement Materials: Sales dropped $91M and EBIT fell $28M due to lower volumes in the Americas and Asia Pacific (impacted by tire customer production levels and inventory management) and increased competitive intensity.
  • Performance Chemicals: Sales decreased $11M, but EBIT increased $3M due to higher gross profit per ton driven by favorable product mix and cost management, offsetting weaker demand in Europe.
• Restructuring Charges: The company recorded $7 million in restructuring charges in Q1 2026, primarily related to the "2026 PC Plan" involving the fumed metal oxide product line and the planned cessation of fumed silica production in Barry, Wales.
• Acquisition: The company closed the acquisition of a carbon black facility in Mexico for approximately $70 million on January 31, 2026 (post-period end).

Guidance, Outlook, and Risks

• Outlook: Management expects Reinforcement Materials EBIT to decline sequentially in Q2 2026 due to lower pricing outcomes from annual tire customer agreements, though volumes are expected to improve seasonally. Performance Chemicals EBIT is expected to be relatively flat sequentially, with higher seasonal volumes offset by higher costs.
• Capital Spending: Full-year fiscal 2026 capital expenditures are expected to be between $200 million and $230 million. This includes approximately $270 million total for EPA compliance controls at U.S. carbon black plants, of which $251 million has been incurred as of December 31, 2025.
• Tax Rate: The operating tax rate for fiscal 2026 is projected to be in the range of 27% to 29%.
• Risks & Contingencies:
  • Respirator Liabilities: A reserve of $33 million exists for pending and future respirator claims. Management notes it is reasonably possible that liabilities could change materially in the near term.
  • Supply Chain: Dow, a fence-line partner in Wales, announced it will cease polysiloxane operations by mid-2026. Cabot has amended agreements to include compensation mechanisms and plans to cease fumed silica production at the site in Q4 2026.
  • Geopolitical/Economic: Risks include volatility in energy/raw material prices, trade relations, and currency exchange controls (specifically noted in Argentina).

Investor Verification Checklist

• Volume Drivers: Verify the extent of inventory destocking by tire customers in the Americas and competitive intensity in Asia Pacific impacting Q1 volumes.
• Restructuring Costs: Monitor the execution of the $25 million total expected cost for the 2026 Performance Chemicals restructuring plan, specifically the $11 million in accelerated depreciation and $7 million in demolition costs.
• Wales Facility: Confirm the timeline and financial impact of the cessation of fumed silica production in Barry, Wales, and the status of the amended supply agreement with Dow.
• Respirator Reserve: Review updates on the $33 million respirator liability reserve and any changes in the number or nature of pending claims.
• Share Repurchases: Note the company repurchased $52 million of common stock in Q1 2026, with approximately $8.7 million remaining under the current authorization.